Fairfield Financial Advisors, LTD Jazz Pharmaceuticals PLC Transaction History

Fairfield Financial Advisors, LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 04, 2024	SELL	$122.0 - $145.31 $7,320 - $8,718	-60 Closed	0 $0
Q2 2023 Nov 04, 2024	BUY	$122.5 - $147.16 $7,350 - $8,829	60 New	60 $7.44 Million
Q1 2023 Nov 04, 2024	BUY	$133.98 - $160.47 $8,038 - $9,628	60 New	60 $8.7 Million
Q3 2022 Oct 07, 2024	BUY	$126.59 - $161.18 $7,595 - $9,670	60 New	60 $8 Million
Q2 2022 Oct 07, 2024	BUY	$141.59 - $168.66 $8,495 - $10,119	60 New	60 $9.36 Million
Q1 2022 Oct 07, 2024	BUY	$129.64 - $160.7 $7,778 - $9,642	60 New	60 $9.34 Million

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.76B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Fairfield Financial Advisors, LTD, based on Form 13F filings with the SEC.

Stay updated on Fairfield Financial Advisors, LTD with notifications on news.